DOCSLIB.ORG

Annual Report 1998

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 1998 ANNUAL REPORT 1998 COLD SPRING HARBOR LABOR Ift-$1121`, 7:Wit . .1: -sr.sb COLD SPRING HARBOR LABORATORY ANNUAL REPORT 1998 ©1999 by Cold Spring Harbor Laboratory Cold Spring Harbor Laboratory P.O. Box 100 1 Bungtown Road Cold Spring Harbor, New York 11724 Website: http://www.cshl.org Managing Editor Wendy Goldstein Editorial staff Dorothy Brown, Cynthia Allen, Dawn McCoy Nonscientific Photography Margot Bennett, Ed Campodonico, Bill Dickerson, Mariana Emmons Desktop Editor Susan Schaefer Cover designer Tony Urgo Book designer Emily Harste Front cover: Female gametophytes in whole-mount ovules of Arabidopsis thaliana are visualized by enhancer-trap-driven expres- sion of a reporter gene encoding for the ri-glucoronidase (GUS) pro- tein. The enhancer-trap technique was developed at CSHL in 1995 by Rob Martienssen and Venkatesan Sundaresan, utilizing the "jumping genes" discovered by Barbara McClintock. (Image cour- tesy of Ueli Grossniklaus.) Back cover: The pond (Marlene Emmons) Section title pages: Marlene Emmons, Ed Campodonico, Bill Dickerson, Sue Lauter Contents Officers of the Corporation/Board of Trustees v Governance and Major Affiliations vi Committees vii Walter H. Page II (1915-1999) viii Jane N. Page (1918-1998)xv PRESIDENT'S ESSAY 1 DIRECTOR'S REPORT 6 Highlights10 ADMINISTRATION REPORT 41 RESEARCH 45 Tumor Viruses 46 Molecular Genetics 71 Cell Biology 105 Structure and Genomics 127 Neuroscience 151 CSHL Fellows 177 Author Index 181 THE SCHOOL OF BIOLOGICAL SCIENCES 183 Dean's Report 184 COLD SPRING HARBOR MEETINGS AND COURSES 187 Academic Affairs189 Symposium on Quantitative Biology 191 Meetings 194 Postgraduate Courses224 Seminars 274 Undergraduate Research 276 Nature Study 278 BANBURY CENTER 279 Director's Report 281 Meetings 287 DNA LEARNING CENTER 319 Director's Report 321 Workshops, Meetings, and Collaborations 333 COLD SPRING HARBOR LABORATORY PRESS 337 Publications 338 Executive Director's Report 339 FINANCE 343 Financial Statements 344 Financial Support348 Grants348 Methods of Contributing357 Capital and Program Contributions358 Nancy and Edwin Marks Imaging Center Capital Campaign 359 The School of Biological Sciences Capital Campaign 360 Annual Contributions361 LABORATORY STAFF 374 Iii Top Row: E. Harlow, W.L. Matheson, W.S. Robertson, J.J. Phelan, Jr., W.E. Murray, J.L. Spingarn, J.R. Reese, C.E. Harris, J.A. Steitz Middle Row: J. Kuriyan, L.N. Grace, W.D. Pidot, M. Ptashne, M.F. Gerry, L.B. Polsky, L.C. Quick, Jr., H.A. Dolan Bottom Row:B. Stillman, W.R. Miller, D.L. Luke Ill, E.S. Marks, J.D. Watson Not shown: C.T. Caskey, S. Hockfield, R. Jaenisch, L.M. Mendell, C.J. Sherr, H. Solomon Officers of the Corporation William R. Miller, Chairman James D. Watson, Ph.D., President Edwin S. Marks, Vice Chairman Bruce Stillman, Ph.D., Director Lola N. Grace, Treasurer G. Morgan Browne, Administrative Director Martha Farish Gerry, Secretary Whitney D. Pidot, Asst. Treasurer Board of Trustees Scientific Trustees C. Thomas Caskey, M.D., F.A.C.P. Martha Farish Gerry James L. Spingarn Merck & Co. Mill Neck, New York Great Neck, New York Edward E. Harlow, Ph.D. Lola N. Grace Howard Solomon Massachusetts General Hospital Glen Head, New York New York, New York Susan Hockfield, Ph.D. Charles E. Harris James D. Watson, Ph.D. Yale University New York, New York Cold Spring Harbor, New York Rudolf Jaenisch, Ph.D. Edwin S. Marks Honorary Trustees Massachusetts Institute of Kings Point, New York Technology Bayard Clarkson, M.D. William L. Matheson Memorial Sloan-Kettering Cancer John Kuriyan, Ph.D. Mill Neck, New York 11765 Center, New York, New York HHMI, Rockefeller University William R. Miller Robert Cummings Lorne M. Mendell, Ph.D. New York, New York Glen Head, New York State University of New York, Stony Brook William E. Murray H. Bentley Glass New York, New York Boulder, Colorado Mark Ptashne, Ph.D. Memorial Sloan-Kettering Cancer John J. Phelan Townsend J. Knight Center Mill Neck, New York New York, New York Charles J. Sherr, M.D., Ph.D. Mary D. Lindsay HHMI, St. Jude Children's Research Whitney D. Pidot Locust Valley, New York New York, New York Bruce Stillman, Ph.D. Cold Spring Harbor Laboratory Leon B. Polsky David L. Luke III New York, New York New York, New York Leslie C. Quick, Jr. Walter H. Page* Individual Trustees Palm Beach, Florida Cold Spring Harbor, New York Helen A. Dolan William S. Robertson Wendy VP. Russell Oyster Bay, New York Huntington, New York Oyster Bay, New York 'deceased Governance and Major Affiliations The Laboratory is governed by a 30-member Board of Trustees which meets three or four times a year. Authority to act for the Board of Trustees between meetings is vested in the Executive Committee of the Board of Trustees. The Executive Committee is composed of the Officers of the Board plus any other members who may be elected to the Executive Committee by the Board of Trustees. Additional standing and ad hoc committees are appointed by the Board of Trustees to provide guidance and advice in specific areas of the Laboratory's operations. Representation on the Board of Trustees itself is divided between community representatives and scientists from major educational and research institutions. The Laboratory is chartered as an educational and research institution by the Board of Regents of the Education Department of the State of New York. It is authorized to operate a graduate program under the name "Cold Spring Harbor Laboratory, Watson School of Biological Sciences" and thereat to confer the degrees of Doctor of Philosophy (Ph.D.), Master of Science (M.S.), and Doctor of Science (Sc.D.), Honorary. It is designated as a "public charity" under Section 501(c)(3) of the Internal Revenue Code. vi Committees Audit Rick Cosnotti Whitney D. Pidot Martha F. Gerry Bruce Stillman, Ph.D. Whitney D. Pidot, Chairman Laurie J. Landeau, V.M.D. William L. Matheson Mary D. Lindsay Robertson House William R. Miller David L. Luke Ill John J. Phelan Wendy Vander Poel Russell William S. Robertson, Chairman James L. Spingarn Art Brings Building James D. Watson, Ph.D. G. Morgan Browne Executive Committee Maude Robertson Helen A. Dolan, Chairman Jan Witkowski, Ph.D. Arthur Brings John P. Cleary, Esq. William R. Miller, Chairman Robertson Research Fund Martha F. Gerry G. Morgan Browne Mary D. Lindsay Lola N. Grace Carl Schafer, Chairman Jack Richards Edwin S. Marks W. Dillaway Ayres, Jr. Wendy V.P. Russell John J. Phelan G. Morgan Browne Elizabeth Watson Whitney D. Pidot Leslie C. Quick, Jr William R. Miller Bruce Stillman, Ph.D. Commercial Relations James L. Spingarn Bruce Stillman, Ph.D. James D. Watson, Ph.D. John P. Phelan, Chairman James D. Watson, Ph.D. Family Representatives G. Morgan Browne Finance and Investment John P. Cleary John P. Maroney Katherine Ernst Lola N. Grace, Chairman William R. Miller Walter Meier, M.D. G. Morgan Browne Bruce Stillman, Ph.D. William S. Robertson Charles E. Harris William D. Keen Compensation Edwin S. Marks Tenure and Appointments William R. Miller William R. Miller, Chairman William E. Murray C. Thomas Caskey, M.D. Lola N. Grace Leon B. Polsky Edward E. Harlow, Ph.D. Whitney D. Pidot William S. Robertson Susan Hockfield, Ph.D. Howard Solomon Rudolf Jaenish, Ph.D. Development John Kuriyan, Ph.D. Nominating Lorne M. Mendell, Ph.D. Leslie C. Quick, Jr. Chairman Mark Ptashne, Ph.D. W. Dillaway Ayres, Jr. Edwin S. Marks, Chairman Charles Sherr, M.D., Ph.D. G. Morgan Browne William R. Miller Bruce Stillman, Ph.D. vii Vjjj Walter Hines Page 11(1915-1999) Walter Hines Page II, whose home looked down on Cold Spring Harbor and out toward Long Island Sound, died on January 8,1999 at the age of 83. A considerate, wise, and effective leader, he spent his entire working life as a banker. Following education at St. Bernard's, Milton Academy, and Harvard University, he joined J.P. Morgan & Co. After wartime service as a naval officer on a submarine chaser in the Atlantic, he steadily moved up Morgan's ranks, becoming a vice president in 1953 and vice chairman of the board in 1968. The latter role reflected his many major successes during the 1960s as head of the company's rapidly expanding international division. In 1971, Walter was pro- moted to Morgan's presidency and was chairman of its board when he retired at the end of 1979. Walter's life was also closely associated with the Cold Spring Harbor Laboratory. Beginning in 1957, he was president of its parent body, the Long Island Biological Association, and starting in 1963, he served several long intervals on its Board of Trustees. Following his retirement from J.P. Morgan, he was for six years (1980-1986) our very able chairman. Walter's roots on Long Island date to his distinguished North Carolina-born grandfa- ther and namesake, Walter Hines Page (1855-1918). A journalist and editor, he founded with Frank Doubleday the publishing house Doubleday-Page, which in 1910 they located in Garden City, New York. Earlier in Boston, the first Walter Hines Page rose to become editor of The Atlantic Monthly and an adviser to the publishers Houghton Mifflin. Doubleday-Page achieved renown when it published Theodore Dreiser's novel Sister Carrie. The decision to publish this novel was made by Walter's grandfather, with Frank Doubleday later wanting to revoke the agreement. But its publication went ahead, albeit in a less sexually explicit form orchestrated by Dreiser's wife at the time, Sara. Soon after, Walter Hines Page founded The World's Work, a monthly magazine that placed great emphasis on the public responsibility of big business. He and Frank Doubleday also start- ed Country Life in America, more immediately a financial success.
Load more

Recommended publications
  • Pnas11148toc 3..7
    December 2, 2014 u vol. 111 u no. 48 u 16975–17336 Cover image: Pictured is a vermillion sea star, Mediaster aequalis,inPorlierPass,British Columbia, that shows signs of sea-star wasting disease. As of June 2014, the disease had affected 20 species of sea stars from Alaska to Baja California, but its cause is unknown. Ian Hewson et al. surveyed sea-star populations and conducted laboratory infection studies. They found that sea-star wasting disease is likely caused by a virus and identified a densovirus as a potential infectious agent. See the article by Hewson et al. on pages 17278–17283. Image courtesy of Peter Luckham (www.divemaster.ca). From the Cover 17278 Potential cause of sea-star wasting disease 17075 Human ability to evaluate probabilities 17122 X-ray free crystallography 17140 DNA binding site recognition by regulatory proteins 17182 Ebola antibodies’ modes of action Contents COMMENTARIES 16982 Going viral and the fatal vulnerability of neurons from immunity, not from infection THIS WEEK IN PNAS Lawrence Steinman See companion article on page 16053 in issue 45 of volume 111 16975 In This Issue 16984 Fuzzy universality of probability judgment Valerie F. Reyna and Charles J. Brainerd See companion article on page 17075 INNER WORKINGS—An over-the-shoulder look at scientists at work 16986 Expanding the femtosecond crystallography toolkit Sol M. Gruner 16977 Inner Workings: Freeing the dinos within See companion article on page 17122 Stephen Ornes CORE CONCEPTS—A brief introduction to emerging topics in science PNAS PLUS 16978 Core Concept: Synthetic biology—change, accelerated 16988 Significance Statements Danielle Venton Brief statements written by the authors about the significance of their papers.
    [Show full text]
  • Hria Medical Foundation 2012 Review
    20․12 DI VISION REVIE W Where Science and Philanthropy Converge IN THIS ISSUE: About Us and Our Services / 2 Funding Opportunities Jeffress Trust /8 Hood Foundation /10 Noonan Memorial Research Fund /11 Klarman Family Foundation /12 King Trust /13 Thome Foundation /14 Smith Family Foundation /16 Davis Foundation /17 Lymphatic Research Foundation /18 Scientific Review Committees /19 Gene Discovery in Anorexia Nervosa / 6 The Medical Foundation, a division of HRiA About Us Since 1957, foundations, bank trusts and individuals have engaged us to create and manage customized biomedical research grant programs that accelerate the pace of scientific discoveries. As evidenced by the more than 145,000 visits to our website this year alone, our funding announcements reach thousands of potential applicants for every grant cycle. And, by building a distinguished Scientific Review Committee for each program, we ensure critical and unbiased selection of the best minds in science. In 2012, we were privileged to work with foundations and bank trust departments whose grant programs distributed more than $18 million to investigators and physician-scientists across the United States and worldwide. Sally E. McNagny, M.D., M.P.H., F.A.C.P., Vice President Since 2001, Dr. McNagny has served as Vice President and head of HRiA’s Medical Foundation division where she leads biomedical research grantmaking and life sciences consulting. Dr. McNagny also serves on the faculty at Harvard Medical School and is a Fellow of the American College of Physicians. She holds a B.S. in Biology from Stanford University, an M.D. from Harvard Medical School, an M.P.H.
    [Show full text]
  • Medical Advisory Board September 1, 2006–August 31, 2007
    hoWard hughes medical iNstitute 2007 annual report What’s Next h o W ard hughes medical i 4000 oNes Bridge road chevy chase, marylaNd 20815-6789 www.hhmi.org N stitute 2007 a nn ual report What’s Next Letter from the president 2 The primary purpose and objective of the conversation: wiLLiam r. Lummis 6 Howard Hughes Medical Institute shall be the promotion of human knowledge within the CREDITS thiNkiNg field of the basic sciences (principally the field of like medical research and education) and the a scieNtist 8 effective application thereof for the benefit of mankind. Page 1 Page 25 Page 43 Page 50 seeiNg Illustration by Riccardo Vecchio Südhof: Paul Fetters; Fuchs: Janelia Farm lab: © Photography Neurotoxin (Brunger & Chapman): Page 3 Matthew Septimus; SCNT images: by Brad Feinknopf; First level of Rongsheng Jin and Axel Brunger; iN Bruce Weller Blake Porch and Chris Vargas/HHMI lab building: © Photography by Shadlen: Paul Fetters; Mouse Page 6 Page 26 Brad Feinknopf (Tsai): Li-Huei Tsai; Zoghbi: Agapito NeW Illustration by Riccardo Vecchio Arabidopsis: Laboratory of Joanne Page 44 Sanchez/Baylor College 14 Page 8 Chory; Chory: Courtesy of Salk Janelia Farm guest housing: © Jeff Page 51 Ways Illustration by Riccardo Vecchio Institute Goldberg/Esto; Dudman: Matthew Szostak: Mark Wilson; Evans: Fred Page 10 Page 27 Septimus; Lee: Oliver Wien; Greaves/PR Newswire, © HHMI; Mello: Erika Larsen; Hannon: Zack Rosenthal: Paul Fetters; Students: Leonardo: Paul Fetters; Riddiford: Steitz: Harold Shapiro; Lefkowitz: capacity Seckler/AP, © HHMI; Lowe: Zack Paul Fetters; Map: Reprinted by Paul Fetters; Truman: Paul Fetters Stewart Waller/PR Newswire, Seckler/AP, © HHMI permission from Macmillan Page 46 © HHMI for Page 12 Publishers, Ltd.: Nature vol.
    [Show full text]
  • Prion Diseases in Knock-In Mice Carrying Single Prp Codon Substitutions Associated with Human Diseases
    Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases Walker S. Jacksona,b,c,1, Andrew W. Borkowskia,b,c, Nicki E. Watsona, Oliver D. Kingd, Henryk Faase, Alan Jasanoffe,f, and Susan Lindquista,b,c,2 aWhitehead Institute for Biomedical Research, Cambridge, MA 02142; bHoward Hughes Medical Institute, cDepartment of Biology, and fDepartments of Biological Engineering, Brain and Cognitive Sciences, and Nuclear Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; dDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA 01655; and eFrances Bitter Magnet Laboratory, Cambridge, MA 02139 Contributed by Susan Lindquist, July 9, 2013 (sent for review March 7, 2013) In man, mutations in different regions of the prion protein (PrP) linked to it, provides an important general model for such are associated with infectious neurodegenerative diseases that investigations. have remarkably different clinical signs and neuropathological There are several types of human prion diseases, each begin- lesions. To explore the roots of this phenomenon, we created ning with pathologic processes in a different brain region and fi – a knock-in mouse model carrying the mutation associated with leading to distinct functional de cits: cognition [Creutzfeldt – – one of these diseases [Creutzfeldt–Jakob disease (CJD)] that was Jakob disease (CJD)], movement control (Gerstmann Sträussler Scheinker syndrome), or sleep and autonomic functions [fatal exactly analogous to a previous knock-in model of a different fl prion disease [fatal familial insomnia (FFI)]. Together with the familial insomnia (FFI)] (7). Prion diseases also af ict animals WT parent, this created an allelic series of three lines, each express- and include bovine spongiform encephalopathy (BSE) of cattle, scrapie of sheep and goats, and chronic wasting disease (CWD) ing the same protein with a single amino acid difference, and with of deer and elk (1).
    [Show full text]
  • Structure & Symmetry
    HAPPY HOLIDAYS ASBMB MEMBERS December 2008 Structure & Symmetry American Society for Biochemistry and Molecular Biology J\\PfliGifk\`ej n`k_*.#'''>=G$kX^^\[FI=Zcfe\j 8 $@C- 9 "@C- : ; >=G$kX^^\[Kil\FI=Zcfe\jXi\kiXej]\Zk\[`ekf?<B)0* Z\ccjXe[k_\kX^^\[gifk\`ejXi\m`jlXc`q\[[li`e^@C$- `e[lZ\[elZc\XikiXejcfZXk`feJK8K*#gXe\c8Xe[9 Xe[`e Ôcfgf[`XXe[jki\jjÔY\i]fidXk`fe8Zk`e#gXe\c:Xe[; % Kil\FI= Fi`>\e\jXclk\j >\efd\n`[\FI=Zcfe\j k_\>=Gg`fe\\ij ]fik_\`iEfY\c ]fikX^^\[gifk\`e\ogi\jj`fe Gi`q\XnXi[ ×:$k\id`eXckX^f]>=G ×J\hl\eZ\m\i`Ô\[Xe[^lXiXek\\[ ×<Xj`cpj_lkkc\[`ekf)'[\jk`eXk`fem\Zkfij ×KiXej]\Zk`fe$i\X[p1('l^gcXjd`[;E8 fi`^\e\%Zfd&fi] ORG-041-GFPTaggedAd_ASBMB_v7.indd 1 10/20/08 12:29:39 PM contents DECEMBER 2008 ON THE COVER: Captivated by the symmetry society news of molecular structure, Sung-Hou Kim has been a 2 From the Editor leader in revealing symmetry 3 President’s Message through his studies in crystallography and 5 Letters to the Editor structural genomics. 30 6 Washington Update 12 Retrospective: Anthony G. San Pietro FASEB releases new Breakthroughs in special interest Bioscience. 6 13 Science’s Role in Foreign Policy 14 ASBMB Round Table: Jim Wells and Mary Woolley 16 Keeping Women in Science 19 Grammar and Writing Tips 2009 meeting 20 The 2009 Fritz Lipmann Lectureship: Douglas C. Rees 21 The 2009 ASBMB Merck Award: John Kuriyan 22 The 2009 FASEB Excellence in Science Award: Susan Lindquist science focus 30 Sung-Hou Kim: Consummate Crystallographer departments 7 News from the Hill 10 Member Spotlight 23 Education and Training A leaky pipeline for women scientists.
    [Show full text]
  • Susan Lee Lindquist (1949–2016)
    In Memoriam Sue was a spectacular scientist who com- at the University of Chicago, where she bined a searing intellect with deep wis- would later join the faculty (1978) and rise Susan Lee Lindquist (1949–2016) dom, sagacious intuition, and limitless to full professor (1988). While at the Uni- creativity. These characteristics enabled versity of Chicago, Sue married Edward Sue to make connections across dispa- Buckbee and would have two wonderful 1, James Shorter * rate disciplines that nobody else could daughters, Alana and Nora. She also make. Her infectious esprit for scientific launched a remarkable and radical series Lindquist was a visionary and pio- discovery was combined with disarming of trailblazing discoveries. These contin- neer who transformed our under- warmth, positivity, openness, directness, ued when Sue moved her research pro- standing of how protein folding and generosity, which made her an inspi- gram to the Whitehead Institute for rational, nurturing, and indefatigable men- Biomedical Research at Massachusetts sculpts biology, evolution, and dis- tor. These synergistic traits empowered Institute of Technology (MIT), which is ease. She revealed several unantici- extraordinarily effective collaborations where I trained with Sue as a postdoctoral pated mechanisms by which protein between scientists from diverse back- fellow (2002–2007). Sue would spend the folding can buffer, release, and grounds and disciplines. Indeed, rest of her career at the Whitehead Insti- potentiate genetic variation in researchers from diverse backgrounds – tute as Director (2001–2004), Institute response to environmental stress, physicists, chemists, biochemists, biolo- Member (2001–2016), and Professor of thereby enabling the rapid evolution gists, mathematicians, and physicians – Biology at MIT (2001–2016).
    [Show full text]
  • Wang-Cv-July2017.Pdf
    CURRICULUM VITAE Samuel Sheng-Hung Wang, Ph.D. Born: May 4, 1967 Address: Neuroscience Institute, Princeton University, Princeton, NJ 08544 Telephone: (609) 258-0388 FAX: (609) 258-1028 E-mail: sswang [at] princeton.edu Web: http://synapse.princeton.edu Research interests 1) Neuroscience – integrative role of the cerebellum in sensory learning and autism 2) Optical methods for observing and manipulating living brain tissue 3) Statistical analysis of data in neuroscience, development, and politics Education 1980-1982 Riverside Poly High School, Riverside, California 1982-1986 B.S. with honor, Physics, California Institute of Technology 1986-1993 Ph.D., Neurosciences, Stanford University (advisor: Stuart H. Thompson) Professional positions 1994-1995, 1996-1997 Postdoctoral fellow, Duke University (with George J. Augustine) 1995-1996 Congressional Science Fellow, Senate Committee on Labor and Human Resources (with Senator Edward M. Kennedy) 1997-1999 Postdoctoral Member of Technical Staff, Biological Computation Res. Dept., Bell Labs Lucent Technologies (with David W. Tank and Winfried Denk) 2000-2006 Assistant Professor, Department of Molecular Biology, Princeton University 2006-2015 Associate Professor, Department of Molecular Biology and Princeton Neuroscience Institute, Princeton University 2013- Faculty associate, Princeton Program in Law and Public Affairs 2014- Faculty affiliate, Cognitive Science 2015- Professor, Princeton Neuroscience Institute and Department of Molecular Biology, Princeton University 2015- Faculty affiliate, Program
    [Show full text]
  • Calcineurin Determines Toxic Versus Beneficial Responses to Α-Synuclein
    Calcineurin determines toxic versus beneficial responses to α-synuclein Gabriela Caraveoa,b, Pavan K. Aulucka,c,1, Luke Whitesella, Chee Yeun Chunga, Valeriya Barua,b, Eugene V. Mosharovd, Xiaohui Yane, Manu Ben-Johnyf, Martin Sosteg, Paola Picottig, Hanna Kime, Kim A. Caldwelle, Guy A. Caldwelle, David Sulzerd,h, David T. Yuef, and Susan Lindquista,b,2 aWhitehead Institute for Biomedical Research, Cambridge, MA 02142; bHoward Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; cDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; Departments of dNeurology and hPsychiatry, Columbia University Medical Center, New York, NY 10032; eDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, AL 35487; fDepartments of Biomedical Engineering and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21205; and gDepartment of Biology, Institute of Biochemistry, Eidgenossische Technische Hochschule Zurich, Zurich CH-8093, Switzerland Contributed by Susan Lindquist, July 15, 2014 (sent for review May 7, 2014) + Calcineurin (CN) is a highly conserved Ca2 –calmodulin (CaM)- tigations, given their genetic tractability and the remarkable + + dependent phosphatase that senses Ca2 concentrations and trans- conservation of Ca2 -signaling pathways from yeast to humans duces that information into cellular responses. Ca2+ homeostasis (14, 15). Moreover, the expression of human α-syn in yeast leads is disrupted by α-synuclein (α-syn), a small lipid binding protein to cellular pathologies directly relevant to neurons and PD, in- whose misfolding and accumulation is a pathological hallmark of cluding nitrosative stress (16, 17), defects in vesicle trafficking several neurodegenerative diseases. We report that α-syn, from (18–20), and faulty mitochondrial function (21, 22).
    [Show full text]
  • Division of Extramural Activities Annual Report 2002
    Division of Extramural Activities Annual Report 2002 National Institutes of Health National Cancer Institute Molecular Diagnosis of Cancer Gene expression profiling using DNA microarrays is a technology that arose as a consequence of the Human Genome Project. With DNA microarrays, it is possible to determine the activity (“expression”) of tens of thousands of genes in parallel on microarray plates. The expression of genes influences the biological behavior of a cell because it dictates which proteins the cell can make and gives cells their unique characteristics. In the DNA microarray images shown at the bottom of the cover illustration, each spot represents a different human gene. Red, yellow, and green spots indicate that a gene is expressed at high, intermediate, and low levels, respectively. The pattern of expression of all of the genes in a cell constitutes its gene expression “profile.” Using DNA microarrays, different types of normal and malignant cells can be distinguished from one another because they have distinct gene expression profiles. Shown at the top of the cover illustration are photomicrographs of lymph node biopsies from two patients with diffuse large B cell lymphoma. The tumor at the right belongs to the germinal center B cell-like subgroup of diffuse large B cell lymphoma. Patients with this lymphoma type have a relatively favorable 5-year survival rate of 59% following multi-agent chemotherapy. The tumor at the left belongs to the activated B cell-like subgroup of diffuse large B cell lymphoma. Patients with this lymphoma type have a less favorable 5-year survival rate of 31%. Although the tumors from these patients were indistinguishable histologically, they had striking differences in their gene expression profiles, as exemplified by the microarray images shown below each lymphoma subgroup.
    [Show full text]
  • WCBR Program3
    Welcome to the Thirty-Fifth Annual Winter Conference on Brain Research The Winter Conference on Brain Research (WCBR) was founded in 1968 to promote free exchange of information and ideas within neuroscience. It was the intent of the founders that both formal and informal interactions would occur between clinical and laboratory based neuroscientists. During the past thirty years neuroscience has grown and expanded to include many new fields and methodologies. This diversity is also reflected by WCBR participants and in our program. A primary goal of the WCBR is to enable participants to learn about the current status of areas of neuroscience other than their own. Another objective is to provide a vehicle for scientists with common interests to discuss current issues in an informal setting. On the other hand, WCBR is not designed for presentations limited to communicating the latest data to a small group of specialists; this is best done at national society meetings. The program includes panels (reviews for an audience not neces- sarily familiar with the area presented), workshops (informal discussions of current issues and data), and a number of posters. The annual conference lecture will be presented at the Sunday breakfast on Sunday, January 27. Our guest speaker will be Dr. Donald Kennedy, Editor-in-Chief of Science. On Tuesday, January 29, a town meeting will be held for the Aspen/Snowmass commu- nity at which Dr. George Ricaurte, and WCBR participants will discuss drug addiction and toxicity of addictive drugs. Also, participants in the WCBR Outreach Program will present sessions at local schools throughout the week to pique students’ interest in science.
    [Show full text]
  • NIH Conflict of Interest Regs Revised
    OCTOBEROCTOBER 2005 www.asbmb.org Constituent Society of FASEB AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY NIH Conflict of Interest Regs Revised SEE PAGE 30 FOR NEW CLARA BENSON TRAVEL FELLOWSHIP AWARD Held in conjunction with EB2006 Custom Antibodies Your Way! Choose the protocol that is right for you! QwikScreen ™: 65 day, 2 rabbit protocol - 4 immunizations, 3 bleeds/rabbit (~100ml serum), customer supplied peptide/protein - Options: Peptide synthesis, immunograde Conjugation to carrier u ELISA u u Animal extensionsMS analysis $685 Standard: 80 day, 2 rabbit protocol - 5 immunizations, 5 bleeds/rabbit (~ 200ml ser Options: um), ELISA, customer supplied peptide/pr Peptide synthesis MS Check™ peptide sequence confirmation u HPLC purified peptide Affinity purification otein - Pinnacle: $975 u HPLC and MS analysis u Complete Affinity Purified Protocol- Animal extensions 2 rabbit pr 5 bleeds/rabbitotocol, (~ 200mlepitope serum), design, peptide PhD technical synthesis support, (up to 20mer),5 immunizations, HPLC purified to ~85%, 5+mg peptide to customer, ELISA, evaluation period, affinity purification, and morMS Check™ peptide sequence confirmationNo Hidden Charges! e… - Discounts for Multiple Protocols$1795 , Includes peptide sequencing by CID MS/MS– u Guaranteed Peptide Let our enthusiasm for scienceExpert workTechnical for SupportFidelity! P: 508.303.8222 www.21stcenturybio.com Toll-free: 877.217.8238 F: 508.303.8333 you! E: [email protected] www.asbmb.org AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY OCTOBER
    [Show full text]
  • The New Eppendorf Micro Centrifuge
    The new Eppendorf Micro Centrifuge. • With 50% higher::capacity,: variable speed,. quieter operation, and .......... Brand ...: .......... Higher capacity..,plus. Safe and ru ggecJ. The new..1.8-place. Model 5415 The" Eppe~dorf 5415 Micro Micro Centrifuge g wes you Centrifuge is UL listed for ~.i.mportant operating advantages-- • . safety: It's sorugged th.atan with unique Eppendorf quality: : acci.den~tatlyiunbalanced 4oad ......... Enclosed rotor design reduces air.turbulence won't cause excessive vibration Versatile in use, and noise. Tubes are angled precisely at 45°.to 0rm0tof~ damage. M.odel.5415 has a variable-speed maximize pellet formation. For more information:: call " ' ~ : " motor that reaches a maximum 800~645-3050;. in NewYork., . of.14,000 rpm with anlRCF of 5164334.~7500.,:. Or write . 16,000 x g;. a 30-minute:timer; Brinkmann..Ins.truments, Inc., • and a momentary button for short Cantiague Road,. Westbury, spins. It accepts 1.5 mL,.500 t~L, NY 11590. (In Canada ................... 400 I~L, and 250 #L Eppendorf 416-~675W911; 50 Galaxy Blvd., •Microcentrifuge Tubes and Rexdale., Ont. M9W 4Y5) blood Collection microtubes, such as B-D Microtainer*Tubes. Specifications ......... Maximumspeed: l4,000i;pm " New rotor design. Maximum RCF ...... : 16.000 x g The enclosedrotor design Test-tube capacity ':: 1:.8 ...... reduces air turbulencefor Timerequired for " - " maximum speed i....10.sec. quieter operation:. And the new Timerequired to stop I~2 sec ........ - Quick, release feature; aitowsthe18-position :.Dimensions quick,reie.ase featu re lets.you rotor to be easily transported even.when ....... (L X W x H): 28 X 2! x 28.5 cm transport the: rotor with tubes--- Loaded .....
    [Show full text]